DURECT CORP (DRRX)

DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.

Address

10240 BUBB ROAD
CUPERTINO, CA 95014

Founded

1998

Number of Employees

58

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)